ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
81 hedge funds and large institutions have $127M invested in Antares Pharma, Inc. in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
79% less call options, than puts
Call options by funds: $63K | Put options by funds: $294K
Holders
81
Holding in Top 10
1
Calls
$63K
Puts
$294K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$3.25M | |
| 3 | +$1.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$804K |
| 5 |
FMA
FNY Managed Accounts
New York
|
+$244K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$598K | |
| 3 | -$398K | |
| 4 |
Renaissance Technologies
New York
|
-$221K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$152K |